Long-term protection at 20- to 31-years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term protection at 20- to 31-years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2019-07-24
DOI
10.1080/21645515.2019.1646575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Be cautious for exceptional results in evaluating the effect of adolescent booster of hepatitis B vaccine
- (2018) Yi-Hua Zhou INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study
- (2018) Yu-ting Yang et al. VACCINE
- Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
- (2017) H. LI et al. EPIDEMIOLOGY AND INFECTION
- Time to re-evaluate the effect of the adolescent booster of hepatitis B vaccine
- (2017) Ellie Carmody INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature?
- (2017) Terence T. Lao Human Vaccines & Immunotherapeutics
- Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose
- (2016) Michael G. Bruce et al. JOURNAL OF INFECTIOUS DISEASES
- Immune persistence after hepatitis B vaccination in infancy – Fact or fancy?
- (2016) Terence T. Lao Human Vaccines & Immunotherapeutics
- Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China
- (2016) Zhen-Zi Wang et al. Human Vaccines & Immunotherapeutics
- Long-term persistence of immunity after hepatitis B vaccination: A fact, not a fancy
- (2016) Andrea Trevisan Human Vaccines & Immunotherapeutics
- Estimating the global prevalence of hepatitis B
- (2015) Jennifer H MacLachlan et al. LANCET
- The long-term efficacy, 13–23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China
- (2015) Feng Wang et al. VACCINE
- The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy
- (2014) Masoomeh Bagheri-Jamebozorgi et al. Human Vaccines & Immunotherapeutics
- Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong
- (2013) Ada Wai-chi Lin et al. JOURNAL OF HEPATOLOGY
- Hepatitis B and the Need for a Booster Dose
- (2011) E. Leuridan et al. CLINICAL INFECTIOUS DISEASES
- Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: Results of a randomized placebo-controlled trial cohort from China where endemicity is high
- (2011) Qian Wu et al. VACCINE
- Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster Dose
- (2009) Brian J. McMahon et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in China
- (2009) Xiaofeng Liang et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
- (2009) Yong Poovorawan et al. VACCINE
- Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization
- (2008) Chun‐Yi Lu et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth
- (2008) Stephanie R. Bialek et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started